Characterization of germline TP53 splicing mutations and their genetic and functional analysis

J M Varley,C Attwooll,G White,G McGown,M Thorncroft,A M Kelsey,M Greaves,J Boyle,J M Birch

DOI: https://doi.org/10.1038/sj.onc.1204369

IF: 8.756

2001-05-10

Oncogene

Abstract:Germline TP53 splicing mutations have been described infrequently (>2%) in the literature, however in a series of 40 patients and families identified by our group in which there are germline TP53 mutations, seven affect splicing (18%). The low figure reported in the literature might reflect the method of mutation detection, which in many studies does not include all splice junctions. These data indicate that a significant proportion of TP53 germline mutations are currently unrecognized. We have carried out detailed studies of the effects of the different mutations on splicing, and see distinct variations in the effects of the same mutation in different patients. Furthermore we have identified the usage of a non-consensus splice donor site in four families with an intron 4 splice donor mutation.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the characterization, genetic and functional analysis of **germline splicing mutations in the TP53 gene**. Specifically, the researchers are concerned about the reasons why these mutations are less reported in the literature and the specific impacts of these mutations on the splicing process. The paper points out that although the proportion of germline TP53 splicing mutations reported in the literature is relatively low (about 42%), in 40 patients and families studied by them, 18% of germline TP53 mutations affected splicing (7 cases). This may reflect the limitations of mutation detection methods, as many studies did not include all splicing sites.

The main objectives of the study include:
1. **Detailed study of the impacts of different mutations on splicing**: The researchers studied the specific impacts of these mutations by analyzing transcripts from mutant alleles.
2. **Identification of the use of non - consensus splicing donor sites**: In four families with exon 4 splicing donor mutations, the researchers discovered the use of a non - consensus splicing donor site, which is a previously unreported phenomenon.
3. **Evaluation of the functional consequences of mutations**: The functional impacts of these mutations were evaluated through multiple functional experiments (such as yeast functional assays, G1 - phase arrest and survival experiments after low - dose - rate irradiation).

In summary, this paper aims to fill the gap in the understanding of germline splicing mutations in the TP53 gene and provide a detailed analysis of these mutations at the genetic and functional levels in order to better understand their roles in cancer susceptibility.